Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Fasting blood sugar >= 126 mg/dl and up to 200 mg/dl. 2.Postprandial blood >= 200 mg/dl and up to 350 mg/dl.
Exclusion criteria
Exclusion criteria: 1.Patients in 60 years age group. 2.Patients of IDDM or juvenile onset diabetes. 3.Patients of Type-2DM with severe grade blood glucose levels (fasting >200 mg/dl and PP >350 mg/dl) 4.Patients of severe Diabetic complications such as cardiopathy, nephropathy, foot Gangrene etc and other endocrine disorders. 5.Pregnant and Lactating Mothers. 6.History of recurrent infections.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The selected drug may interfere in the basic mechanism of glycemic control, regulate dyslipidemia etc. The selected drug may interfere in the mechanism of oxidative stress and the expression levels of selected genes in Type 2 DM and it help to explore the mechanism of action. Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The present study may be providing a lead to the researchers working in the area of traditional diabetes drug development.Timepoint: 3 months | — |
Countries
India
Contacts
Banaras Hindu University